MiR-146a is over-expressed and controls IL-6 production in cystic fibrosis macrophages

Francesco R. Luly (1) , Manuella Leveque (2, 1) , Valerio Licursi (1) , Giuseppe Cimino (3) , Corinne Martin-Chouly (4) , Nathalie Théret (4, 5) , Rodolfo Negri (1) , Luca Cavinato (1) , Fiorentina Ascenzioni (1) , Paola del Porto (1)

1 UNIROMA - Università degli Studi di Roma "La Sapienza" = Sapienza University [Rome]
2 CHU de Poitiers - Centre hospitalier universitaire de Poitiers = Poitiers University Hospital
3 Policlinico Umberto I [Rome, Italy]
4 Irset - Institut de recherche en santé, environnement et travail
5 EHESP - École des Hautes Études en Santé Publique [EHESP]

Cystic fibrosis (CF) is an inherited disease that is characterised by susceptibility to bacterial infections and chronic lung inflammation. Recently, it was suggested that macrophages contribute to impaired host defence and excessive inflammatory responses in CF. Indeed, dysfunction attributed to CF macrophages includes decreased bacterial killing and exaggerated inflammatory responses. However, the mechanisms behind such defects have only been partially defined. MicroRNAs (miRNAs) have emerged as key regulators of several macrophage functions, including their activation, differentiation and polarisation. The goal of this study was to investigate whether miRNA dysregulation underlies the functional abnormalities of CF macrophages. MiRNA profiling of macrophages was performed, with 22 miRNAs identified as differentially expressed between CF and non-CF individuals. Among these, miR-146a was associated with significant enrichment of validated target genes involved in responses to microorganisms and inflammation. As miR-146a dysregulation has been reported in several human inflammatory diseases, we analysed the impact of increased miR-146a expression on inflammatory responses of CF macrophages. These data show that inhibition of miR-146a in lipopolysaccharide-stimulated CF macrophages results in increased interleukin-6 production, which suggests that miR-146a overexpression in CF is functional, to restrict inflammatory responses.

Domaines: Sciences du Vivant [q-bio]

Francesco R. Luly, Manuella Leveque, Valerio Licursi, Giuseppe Cimino, Corinne Martin-Chouly, et al.. MiR-146a is over-expressed and controls IL-6 production in cystic fibrosis macrophages. Scientific Reports, 2019, 9 (1), pp.16259. ⟨10.1038/s41598-019-52770-w⟩. ⟨hal-02391717⟩